EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Pneumocystis carinii pneumonia in CD40L-deficient mice with CD40 ligand gene therapy



Treatment of Pneumocystis carinii pneumonia in CD40L-deficient mice with CD40 ligand gene therapy



Journal of Investigative Medicine 49(1): 142A, January




(PDF 0-2 workdays service: $29.90)

Accession: 035980580

Download citation: RISBibTeXText



Related references

CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. Journal of Immunology 155(7): 3525-3529, 1995

CD40 ligand administration induces pneumocystis-specific cell-mediated and humoral immunity in CD40L-deficient mice suffering from spontaneous pneumocystosis. Blood 88(10 SUPPL 1 PART 1-2): 655A, 1996

Recombinant CD40 ligand administration does not decrease intensity of Pneumocystis carinii infection in scid mice. Journal of Eukaryotic Microbiology Suppl: 153s-154s, 2002

Recombinant CD40 ligand administration does not decrease intensity of Pneumocystis carinii infection in scid mice. Supplement to the Journal of Eukaryotic Microbiology (2001): 153S-154S, 2001

Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice. Journal of Leukocyte Biology 84(2): 420-430, 2008

Administration of purified recombinant trimeric CD40 ligand augments humoral and cell-mediated immune responsiveness in CD40L-deficient mice. Blood 86(10 SUPPL 1): 596A, 1995

Transmission electron microscopic observations of pneumocystis carinii and pneumocystis carinii pneumonia in nude mice. Japanese Journal of Parasitology 35(4): 339-354, 1986

Studies on pneumocystis carinii and pneumocystis carinii pneumonia part 1 evaluation of several kinds of staining method in the identification of pneumocystis carinii. Japanese Journal of Parasitology 26(3): 116-126, 1977

Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. International Journal of Antimicrobial Agents 18(6): 547-551, 2001

Studies on pneumocystis carinii and pneumocystis carinii pneumonia part 2 methods or concentration and quantitation of pneumocystis carinii cysts. Japanese Journal of Parasitology 26(5): 314-322, 1977

Pneumocystis carinii pneumonia in mutant mice deficient in both TCRalphabeta and TCRgammadelta cells: cytokine and antibody responses. Journal of Infectious Diseases 179(2): 455-459, 1999

Pneumocystis carinii and pneumocystis carinii pneumonia 7. chemo therapy of 42 clinical cases. Japanese Journal of Parasitology 28(6): 455-464, 1979

Treatment and prevention of pneumocystis carinii pneumonia and further elucidation of the pneumocystis carinii life cycle with 1 3 beta glucan synthesis inhibitor l 671329. Journal of Protozoology 38(6): 151S-153S, 1991

Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(2): 201-206, 1999